<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2199</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>SYNTHESIS AND BIOLOGICAL EVALUATION OF 3,5- DIARYL-1-PHENYL-2-PYRAZOLINES AS ANTIBACTERIAL, ANTI-INFLAMMATORY AND ANALGESIC AGENTS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Anjan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rout</surname><given-names>Sradhasini</given-names></name></contrib><contrib contrib-type="author"><name><surname>Panda</surname><given-names>Chandrasekar</given-names></name></contrib><contrib contrib-type="author"><name><surname>M.B.V.Raju</surname><given-names/></name></contrib></contrib-group><volume/><issue/><fpage>42</fpage><lpage>54</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>In a wide search program towards an efficient antibacterial, anti-inflammatory and analgesic&#13;
agents, a series of 3,5-diaryl-1-phenyl-2-pyrazoline were synthesized starting from substituted __ampersandsignalpha;,&#13;
__ampersandsignbeta; unsaturated carbonyl compounds which undergo cyclization reactions with phenylhydrazine.&#13;
The synthesized compounds were characterized and confirmed on the basis of FT-IR, 1HNMR,&#13;
13CNMR and mass spectral data. The synthesized compounds 3,5-diaryl-1-phenyl-2-pyrazolines&#13;
had shown significant activity against Staphylococcus aureus (MTCC 87), Escherichia Coli&#13;
(MTCC 40), Pseudomonas aeruginosa (MTCC 424) and Proteus vulgaris (MTCC 426) by cup&#13;
plate method using tetracycline-SD 037 as a reference standard. The anti-inflammatory property&#13;
of 1,3,5-diaryl-1-phenyl-2-pyrazolines were screened by using carragenan induced paw edema&#13;
method in Wistar rat. The compounds exhibited significant anti-inflammatory property further&#13;
evaluated for analgesic activity using both acetic acid-induced abdominal writhing method and&#13;
hot plate method respectively in Swiss albino mice. The anti-inflammatory and analgesic&#13;
activities exhibited were comparable to that of the standard drug diclofenac. The safety of 3,5-&#13;
diaryl-1-phenyl-2-pyrazolines were reflected by toxicity studies.&#13;
</p></abstract><kwd-group><kwd>Chalcones; Pyrazolines; Antibacterial; Anti-inflammatory; Analgesic.</kwd></kwd-group></article-meta></front></article>
